Skip to content
Naoki Chiba, M.D., M.Sc.

Naoki Chiba, M.D., M.Sc.

he/him/his

Contact

About Me

Professional Background

I am a Canadian trained physician, attending University of Western Ontario for medical school, then McMaster University, Hamilton, Ontario for Internal Medicine residency and Gastroenterology Fellowship. I did an extra clinical research year and also obtained further training in therapeutic ERCP. I ...
I am a Canadian trained physician, attending University of Western Ontario for medical school, then McMaster University, Hamilton, Ontario for Internal Medicine residency and Gastroenterology Fellowship. I did an extra clinical research year and also obtained further training in therapeutic ERCP. I was in private practice gastroenterology in Guelph, Ontario until 2019 and during that time was clinical faculty at McMaster University, becoming Clinical Professor in 2013. I worked for a 2 year stint in PEI, Canada before coming to URMC.

I have interest in evidence-based medicine with a MSc from McMaster University in clinical epidemiology and biostatistics. I have participated in numerous randomized, controlled trials. I have developed many professional guidelines and teaching programs for physicians. I am a fellow of the American Gastroenterological Association (AGAF 2011), the Canadian Association of Gastroenterology (CAGF 2015) and the American College of Gastroenterology (FACG 2022).

Faculty Appointments

Professor of Clinical Medicine - Department of Medicine, Gastroenterology/Hepatology (SMD)

Credentials

Education

MSc | Canada-McMaster Univ, Hamilton. Health Care Research. 2004

MD | Canada-U Western Ontario, London. Medicine. 1986

Awards

Fellow of the American College of Gastroenterology (FACG). 2022

Fellow of the Canadian Association of Gastroenterology (CAGF). 2015

Fellow of the American Gastroenterological Association (AGAF). 2011

Research

My research interests started with Helicobacter pylori. I published the first meta-analysis (1992) on the treatment of Hp and treatment has been and remains my primary interest (Toronto consensus 2016). I have looked at the effects of Hp on dyspepsia and with the CADET (Canadian Adult Dyspepsia Empi...
My research interests started with Helicobacter pylori. I published the first meta-analysis (1992) on the treatment of Hp and treatment has been and remains my primary interest (Toronto consensus 2016). I have looked at the effects of Hp on dyspepsia and with the CADET (Canadian Adult Dyspepsia Empiric Treatment) study group, we performed a number of relevant, randomized controlled trials to get direct evidence to develop management guidelines for upper GI symptoms/disorders (CanDys guidelines). I am interested in the related areas of upper GI - GERD. I have contributed to national guidelines in GERD consensus conferences. I am an expert in PPI's, a mainstay of treatment of upper GI disorders. Teaching practising physicians has always been a keen interest. I also have background in evidence-based medicine with a masters degree from McMaster University, Hamilton, Canada.